Baixar PDF

Outros usuários também visualizaram estes artigos

Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice Carla Boquimpani; Fernanda Salles Seguro; Gustavo Henrique Romani Magalhães; Ingrid Luise Soares Pinto; Israel Bendit; Jaisson André Pagnoncelli Bortolini; Katia Borgia Barbosa Pagnano; Renato Centrone; Vaneuza Funke;
Hematol Transfus Cell Ther. 2022;44:402-9
Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia Arthur Gomes Oliveira Braga; Katia Borgia Barbosa Pagnano; Marina Dal'Bó Pelegrini Campioni; Ana Beatriz Pascoal Lopes; Gislaine Oliveira Duarte; Konradin Metze; Irene Lorand-Metze;
Hematol Transfus Cell Ther. 2024;46:268-72
An interesting case of chronic myeloid leukemia with twists and turns Thulasi Raman Ramalingam; J. Subramanian; I. Nagarathinam; C. Chandran; L. Vaidhyanathan; J.M. Easow;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S385-8